The liver is a very important part of the body, at high risk of being damaged due to objective and subjective causes. Among the common diseases of the liver, fatty liver is a common disease, which can occur at any age.

Nonalcoholic fatty liver disease is increasingly common, progresses silently, causing many serious complications. This condition is usually caused by excess fat in the liver that affects the function of the liver.

Non-alcoholic steatohepatitis (NASH) is emerging as a leading cause of hepatocellular carcinoma (HCC). Sorafenib is the only first-line therapy for advanced HCC despite its severe side effects.